205 related articles for article (PubMed ID: 32886320)
1. Efficacy and Safety of Fentanyl Citrate Patch, Including a Low-Dose 0.5 mg Formulation, in Opioid-Naïve Patients with Cancer Pain.
Yamaguchi S; Uchida E; Terahara T; Okawa K; Hashimoto F; Tanaka Y
Clin Drug Investig; 2020 Nov; 40(11):1041-1052. PubMed ID: 32886320
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety and pharmacokinetic study of a novel fentanyl-containing matrix transdermal patch system in Japanese patients with cancer pain.
Miyazaki T; Hanaoka K; Namiki A; Ogawa S; Kitajima T; Hosokawa T; Ishida T; Nogami S; Mashimo S
Clin Drug Investig; 2008; 28(5):313-25. PubMed ID: 18407717
[TBL] [Abstract][Full Text] [Related]
3. A new once-a-day fentanyl citrate patch (Fentos Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch.
Koike K; Terui T; Nagasako T; Horiuchi I; Machino T; Kusakabe T; Hirayama Y; Mihara H; Yamakage M; Kato J; Nishisato T; Ishitani K
Support Care Cancer; 2016 Mar; 24(3):1053-9. PubMed ID: 26248654
[TBL] [Abstract][Full Text] [Related]
4. An Open-Label Study of the Pharmacokinetics and Tolerability of Once-a-Day Fentanyl Citrate Patch in Japanese Pediatric and Adolescent Patients with Cancer Pain.
Hiyama E; Yamaguchi S; Okawa K; Hashimoto F; Otaka K; Terahara T
Clin Drug Investig; 2021 Dec; 41(12):1087-1098. PubMed ID: 34784012
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line.
Hoya Y; Okamoto T; Yanaga K
Support Care Cancer; 2010 Jun; 18(6):761-4. PubMed ID: 20354734
[TBL] [Abstract][Full Text] [Related]
6. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.
Mystakidou K; Befon S; Tsilika E; Dardoufas K; Georgaki S; Vlahos L
Oncology; 2002; 62(1):9-16. PubMed ID: 11810038
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe pain.
Kang JH; Oh SY; Song SY; Lee HY; Kim JH; Lee KE; Lee HR; Hwang IG; Park SH; Kim WS; Park YS; Park K
Korean J Intern Med; 2015 Jan; 30(1):88-95. PubMed ID: 25589840
[TBL] [Abstract][Full Text] [Related]
8. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
9. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
10. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
[TBL] [Abstract][Full Text] [Related]
11. A randomized, open, parallel group, multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain.
Kress HG; Von der Laage D; Hoerauf KH; Nolte T; Heiskanen T; Petersen R; Lundorff L; Sabatowski R; Krenn H; Rosland JH; Saedder EA; Jensen NH
J Pain Symptom Manage; 2008 Sep; 36(3):268-79. PubMed ID: 18538974
[TBL] [Abstract][Full Text] [Related]
12. Proportional dose of rapid-onset opioid in breakthrough cancer pain management: An open-label, multicenter study.
Yen TY; Chiou JF; Chiang WY; Su WH; Huang MY; Hu MH; Wu SC; Lai YL
Medicine (Baltimore); 2018 Jul; 97(30):e11593. PubMed ID: 30045291
[TBL] [Abstract][Full Text] [Related]
13. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
Jeal W; Benfield P
Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a single ascending dose study in opioid-naïve healthy volunteers.
Rauck R; Oh DA; Parikh N; Koch C; Singla N; Yu J; Nalamachu S; Vetticaden S
Curr Med Res Opin; 2017 Nov; 33(11):1915-1920. PubMed ID: 28681626
[TBL] [Abstract][Full Text] [Related]
15. Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain.
Arai T; Kashimoto Y; Ukyo Y; Tominaga Y; Imanaka K
Curr Med Res Opin; 2015 Dec; 31(12):2207-18. PubMed ID: 26359327
[TBL] [Abstract][Full Text] [Related]
16. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
[TBL] [Abstract][Full Text] [Related]
17. Analgesic effect of switching from oral opioids to a once-a-day fentanyl citrate transdermal patch in patients with lung cancer.
Takakuwa O; Oguri T; Maeno K; Yokoyama M; Hijikata H; Uemura T; Ozasa H; Ohkubo H; Miyazaki M; Niimi A
Am J Hosp Palliat Care; 2013 Nov; 30(7):726-9. PubMed ID: 23264661
[TBL] [Abstract][Full Text] [Related]
18. [A phase II clinical study of once-a-day fentanyl citrate patch in patients with cancer pain--switching from once-every-three-days fentanyl patch to once-a-day fentanyl citrate patch].
Miyazaki T; Namiki A; Ogawa S; Kitajima T; Masuda Y; Iwao Y; Uchida E; Iseki M; Matoba M; Hashizume T
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1747-52. PubMed ID: 20841939
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a multiple ascending dose study in opioid-naïve healthy volunteers.
Rauck RL; Oh DA; Singla N; Koch C; Parikh N; Nalamachu S; Wilson D; Yu J; Vetticaden S
Curr Med Res Opin; 2017 Nov; 33(11):1921-1933. PubMed ID: 28942715
[TBL] [Abstract][Full Text] [Related]
20. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
